Jay Tibbitts

Jay Tibbitts is an accomplished professional in the field of nonclinical development, currently serving as Vice President at Lycia Therapeutics since November 2024. Prior to this role, Jay was Vice President at Surrozen, where responsibilities included leading nonclinical development and ensuring the timely achievement of key milestones for drug candidates. Jay's extensive experience encompasses leadership positions at AbbVie, UCB, Genentech, XOMA, and Pfizer, with a strong focus on pharmacokinetics, pharmacodynamics, and drug development strategies across various therapeutic areas. Jay holds a Ph.D. in Biopharmaceutical Sciences from the University of California-San Francisco, a D.V.M from The Ohio State University, and a B.S. in Biology and Chemistry from Bowling Green State University.